Transparency Reports and Reporting of Physician Ownership or Investment Interests 
Sec. 1128G. [42 U.S.C. 1320a-7h] (a) Transparency Reports.
This legislation specifies what information manufacturers must include in their reports. This legislation covers “payments or other transfers of value.”
AB 128, Statutes of Nevada Chapter 409 (effective October 1, 2007) requires that all wholesalers or manufacturers who employ a person to sell or market a drug, medicine, chemical, device, or appliance in Nevada must comply with certain requirements regarding their marketing practices. On January 30, 2008, regulations promulgated by the Nevada State Board of Pharmacy to implement AB 128 became effective.
AN ACT CONCERNING REPORTING OF PAYMENTS BY MANUFACTURERS TO INDEPENDENTLY-PRACTICING ADVANCED PRACTICE REGISTERED NURSES.
Not later than July 1,  2017, and [quarterly] annually thereafter, an applicable manufacturer that provides a payment or other transfer of value to an advanced practice registered nurse, who is practicing not in collaboration with a physician in the state, in accordance with subsection (b) of section 20-87a, as amended by this act, shall submit to the Commissioner of Consumer Protection, in the form and manner prescribed by the commissioner, the information described in 42 USC 1320a-7h, as amended from time to time, for the preceding calendar year.
HEALTH AND SAFETY CODE SECTION 119400-119402
Every pharmaceutical company shall adopt a Comprehensive Compliance Program that is in accordance with the April
2003 publication “Compliance Program Guidance for Pharmaceutical Manufacturers,” which was developed by the United States Department of Health and Human Services Office of Inspector General (OIG).